TMO — THERMO FISHER SCIENTIFIC INC.
—
NYSE ·
Unknown ·
Unknown ·
CIK 97745 ·
Last close
$603.01
Market Cap
$222.96B
52W High
$606.21
52W Low
$434.83
ADV30
2,100,273
Next earnings
2026-10-21
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | — | — | — | — | — | — | — |
| Mar 2026 | 11,005,000,000 | 4,430,000,000 | 1,913,000,000 | 1,651,000,000 | 113,281,000,000 | 3,254,000,000 | 61,220,000,000 |
| Dec 2025 | 12,215,000,000 | 5,011,000,000 | 2,303,000,000 | 1,964,000,000 | 110,343,000,000 | 9,852,000,000 | 56,807,000,000 |
| Sep 2025 | 11,122,000,000 | 4,583,000,000 | 2,075,000,000 | 1,616,000,000 | 103,020,000,000 | 1,982,000,000 | 51,866,000,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$8,290,000,000
Investing CF
$-12,483,000,000
Financing CF
$2,995,000,000
CapEx
$-1,539,000,000
Dividends Paid
$-649,000,000
Buybacks
$-4,000,000,000
EPS Diluted TTM
$18.59
As of
2026-08-02
Balance + Analyst (yfinance extras)
Retained Earnings
$60,632,000,000
Inventory
$5,496,000,000
Receivables
$10,888,000,000
ST Investments
$2,000,000
EBIT TTM
$8,892,000,000
Pretax Income TTM
$7,422,000,000
Interest Exp TTM
$1,470,000,000
Analysts
26
Yahoo Snapshot (yfinance, live)
Total Revenue
$46,336,000,000
EBITDA
$11,738,999,808
Free Cash Flow
$6,237,250,048
Enterprise Value
$262,310,100,992
Total Cash
$4,064,000,000
Total Debt
$42,548,998,144
Shares Out
369,747,286
Trailing EPS
$18.51
Book Value
$142.47
ROE
13.5%
ROA
5.1%
Div Yield
0.31%
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 44,557,000,000 | 8,110,000,000 | 6,704,000,000 | 110,343,000,000 | 56,807,000,000 | — | 7,818,000,000 |
| Dec 2024 | 42,879,000,000 | 7,717,000,000 | 6,335,000,000 | 97,321,000,000 | 47,649,000,000 | — | 8,667,000,000 |
| Dec 2023 | 42,857,000,000 | 7,318,000,000 | 5,995,000,000 | 98,726,000,000 | 51,884,000,000 | — | 8,406,000,000 |
| Dec 2022 | 44,915,000,000 | 8,507,000,000 | 6,950,000,000 | 97,154,000,000 | 53,006,000,000 | — | 9,154,000,000 |
TTM Snapshot
Revenues TTM
$41,179,000,000
NetIncome TTM
$6,742,000,000
OpCashFlow TTM
$0
Assets (Latest)
$97,321,000,000
Forward EPS
$27.51
Max Pain — expiry 2026-08-21
max pain strike: $550.00 · spot: $595.93 · call oi: 5,798 · put oi: 3,392Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| IBM | INTERNATIONAL BUSINESS MACHINES CORP | $222.32B | $235.98 | — |
| KLAC | KLA CORP | $272.09B | $208.25 | — |
| KXIAY | Kioxia Holdings Corporation/ADR | $178.29B | $32.58 | — |
| QQQ | INVESCO QQQ TRUST, SERIES 1 | $284.49B | $723.70 | — |
| SMEGF | Siemens Energy AG/ADR | $159.40B | $187.34 | — |
News headlines (Yahoo Finance, 1h cache)
Thermo Fisher closes $1.1B sale of microbiology unit to PE firm
2026-08-13 11:19 · Yahoo
Stronger Q2 Results And New Supply Deal Might Change The Case For Investing In LivaNova (LIVN)
2026-08-12 23:16 · Yahoo
LivaNova (LIVN) Could Be 5% Undervalued Following Raised 2026 Guidance
2026-08-12 22:09 · Yahoo
Astorg Completes Acquisition of Microbiology Business From Thermo Fisher Scientific, Establishing an Independent Global Diagnostics Specialist
2026-08-12 12:10 · Yahoo
Thermo Fisher Scientific Completes Sale of its Microbiology Business to Astorg
2026-08-12 12:00 · Yahoo
Following Hamamatsu's Rebranding of NKT Photonics to Drive Laser Innovation, New Biophotonics Market Overview Maps Strategic Growth Through 2030
2026-08-12 11:20 · Yahoo
Arcturus Therapeutics Eyes Phase III CF Call, OTC Data as Vaccine Funds Pipeline
2026-08-12 01:04 · Yahoo
Can A New Vitiligo Registry Move The Needle For Thermo Fisher (TMO)?
2026-08-11 21:20 · Yahoo
Thermo Fisher Scientific Collaborates with The Michael J. Fox Foundation to Advance Proteomics-Enabled Parkinson’s Precision Medicine
2026-08-11 12:30 · Yahoo
Non-Viral Transfection Reagents Market Report (3rd Edition) by Type of Non-Viral Transfection Method, Application Area, End-User & Region, Featuring Bio-Rad, MaxCyte, MilliporeSigma, Thermo Fisher Sci
2026-08-11 08:45 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.